Lite Strategy LITS
NASDAQ LITS
$0.99 +0.05 (+4.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Short-term Investments (2013 - 2024)

Lite Strategy (LITS) posted quarterly Short-term Investments of $20.0 million for Q3 2024, down 74.62% year-over-year from $78.8 million in Q4 2023, and down 42.26% quarter-over-quarter from $34.6 million in Q2 2024.

Lite Strategy (LITS) Short-term Investments (2013 - 2024) Analysis & Trends

Lite Strategy's Short-term Investments history runs 12 years deep, the most recent figure standing at $20.0 million for Q3 2024.

  • In Q3 2024, Short-term Investments fell 74.62% year-over-year to $20.0 million; the TTM figure through Sep 2024 stood at $20.0 million (down 74.62% YoY), while the FY2024 annual figure was $34.6 million, down 58.66% from the prior year.
  • Short-term Investments for Q3 2024 stood at $20.0 million, down from $34.6 million in the prior quarter.
  • The five-year high for Short-term Investments was $173.2 million in Q4 2021, with the low at $20.0 million in Q3 2024.
  • The 5-year median for Short-term Investments is $123.7 million (2022), against an average of $113.4 million.
  • The sharpest annual moves came in 2020 and 2024: Short-term Investments surged 175.61% in 2020, then slumped 74.62% in 2024.
  • Lite Strategy's Short-term Investments stood at $170.3 million in 2020, then rose by 1.72% to $173.2 million in 2021, then slumped by 34.61% to $113.3 million in 2022, then sank by 52.06% to $54.3 million in 2023, then slumped by 63.17% to $20.0 million in 2024.
  • Business Quant data shows LITS's Short-term Investments at $20.0 million in Q3 2024, $34.6 million in Q2 2024, and $54.2 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Lite Strategy 35.71 Mn 28.17 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 20.00 Mn
Jun 30, 2024 34.64 Mn
Mar 31, 2024 54.20 Mn
Dec 31, 2023 54.30 Mn
Sep 30, 2023 78.80 Mn
Jun 30, 2023 83.79 Mn
Mar 31, 2023 103.20 Mn
Dec 31, 2022 113.26 Mn
Sep 30, 2022 123.71 Mn
Jun 30, 2022 137.51 Mn
Mar 31, 2022 157.93 Mn
Dec 31, 2021 173.20 Mn
Sep 30, 2021 129.88 Mn
Jun 30, 2021 144.88 Mn
Mar 31, 2021 154.88 Mn
Dec 31, 2020 170.27 Mn
Sep 30, 2020 165.18 Mn
Jun 30, 2020 170.30 Mn
Mar 31, 2020 85.36 Mn
Dec 31, 2019 95.24 Mn